Halozyme Therapeutics
HALO
YETI Holdings
YETI
Constellation Brands
STZ
4
Ermenegildo Zegna NV
ZGN
5
Cars.com
CARS
US Stock MarketDetailed Quotes
LIXT Lixte Biotechnology
- 1.190
- +0.010+0.85%
Trading May 7 09:30 ET
3.19MMarket Cap-0.75P/E (TTM)
1.190High1.190Low242Volume1.190Open1.180Pre Close287.98Turnover0.01%Turnover RatioLossP/E (Static)2.68MShares3.50052wk High-1.19P/B3.00MFloat Cap1.02052wk Low--Dividend TTM2.52MShs Float71.900Historical High--Div YieldTTM0.00%Amplitude1.020Historical Low1.190Avg Price1Lot Size
Lixte Biotechnology Key Stats
EPS
According to the latest financial report of Lixte Biotechnology, the latest earnings per share (TTM) for the company is -0.27. Investing in companies with strong earnings per share can potentially provide higher returns.
Currency: USD
Quarterly
Loading...
FCF
Interested in knowing about Lixte Biotechnology's free cash flow? The latest report shows it as -598.68K. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.
Currency: USD
Quarterly
Loading...
Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of Lixte Biotechnology shows that the company's current ratio is 3.60, indicating healthy liquidity.
Currency: USD
Quarterly
Loading...
Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of Lixte Biotechnology, the quick ratio is 3.26, indicating that the company can meet its short-term debt obligations.
Currency: USD
Quarterly
Loading...
ROE
Want to learn more about the financial health of Lixte Biotechnology? The latest ROE figure is -1.60K%, indicating that the company has stable profitability.
Currency: USD
Quarterly
Loading...
ROA
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of Lixte Biotechnology, the total asset return on investment (ROA) is -43.48%.
Currency: USD
Quarterly
Loading...
Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check Lixte Biotechnology's latest financial report to see how their gross margin is doing - currently at --.
Currency: USD
Quarterly
Loading...
Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of Lixte Biotechnology, the net profit margin is -306.93%, which is a good sign for its profitability.
Currency: USD
Quarterly
Loading...
Market Insights
Discussing
Trump 2.0 Era: How will global markets evolve?
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context,
Moo Live
Jan 23 16:54
MicroStrategy Q4 2024 earnings conference call